Search

everythinglearnresearchcommunity

for

Search:↓

Serenoa repens extract, alone or with other supplements, improves urinary symptoms and lowers PSA levels.

Weekly bicalutamide is safe and effective, with 50 mg/week recommended.

5ARI treatment improves PSA test accuracy for prostate cancer diagnosis.

Finasteride therapy reduces PSA levels and prostate size, helping diagnose prostate cancer.

PSA testing is a reliable method for detecting prostate cancer, and opioids may lower PSA levels, but triglycerides don't affect prostate cancer risk.

After prostate removal surgery, higher initial prostate size was linked to higher urethral PSA levels and more severe male pattern baldness.

Low dose finasteride causes only minor changes in PSA levels in men over 50 with BPH.

Higher C-peptide levels in African-American men and higher HbA1c levels in Caucasian men are linked to lower PSA levels.

Finasteride lowers PSA levels about the same whether taken at 1 mg or 5 mg daily.

Low-dose finasteride lowers PSA levels, which can make prostate cancer harder to detect.

Baseline PSA levels affect general health and sexual satisfaction in men with BPH treated with finasteride or placebo.

Finasteride lowers PSA levels and prostate size, requiring adjusted PSA interpretation for accurate cancer screening.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.

Finasteride reduces PSA levels by around 40-50% in BPH patients.

Higher PSA levels can indicate prostate cancer, but there's overlap with non-cancerous conditions.

Finasteride reduces prostate size and PSA levels in young patients.

Finasteride reduces prostate size and PSA levels in young men with hair loss.

Estrogen helps prevent artery plaque by stopping monocyte capture in blood vessels.

Guselkumab effectively reduces fatigue in Psoriatic Arthritis patients over two years.

Finasteride treats enlarged prostate and may help with baldness, but effects on sexual function and male fetuses are unclear.

Finasteride lowers risk of urinary issues and surgery by over 50% in 4 years.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Older men with severe symptoms and larger prostates should focus on prevention, using finasteride and alpha-blockers to manage acute urinary retention.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Finasteride reduces prostate cancer risk but may affect ejaculatory volume and requires careful consideration for young men.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Dutasteride effectively treats benign prostatic hyperplasia but isn't approved for preventing prostate cancer.